{"result": "Here is a comprehensive summary of the data:\n\nSunitinib is a drug that has been evaluated in clinical trials for the treatment of HER2-positive breast cancer, specifically in cases of locally advanced breast cancer (LABC) or inflammatory breast cancer (IBC). Additionally, Sunitinib is an oral multi-tyrosine kinase inhibitor, which means it has the potential to be used in the treatment of breast cancer due to its ability to inhibit multiple tyrosine kinases.", "input": "\nYou are a helpful assistant responsible for generating a comprehensive summary of the data provided below.\nGiven one or two entities, and a list of descriptions, all related to the same entity or group of entities.\nPlease concatenate all of these into a single, comprehensive description. Make sure to include information collected from all the descriptions.\nIf the provided descriptions are contradictory, please resolve the contradictions and provide a single, coherent summary.\nMake sure it is written in third person, and include the entity names so we the have full context.\n\n#######\n-Data-\nEntities: \"\\\"SUNITINIB\\\"\"\nDescription List: [\"\\\"Sunitinib is a drug evaluated in clinical trials for the treatment of HER2- LABC or IBC.\\\"\", \"\\\"Sunitinib is an oral multi-tyrosine kinase inhibitor with potential applications in breast cancer treatment.\\\"\"]\n#######\nOutput:\n", "parameters": {"model": "llama3-8b-8192", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 500, "n": null}}